NeuroPace, Inc., founded in March 2016 and incorporated in Florida (Filed Number: F16000001158), is a key player in the medical device industry with its innovative RNS System designed to manage intractable epilepsy. This system incorporates a small implantable neurostimulator connected via leads to up to two seizure onset areas, working alongside a user-friendly home monitor and an integrated Patient Data Management System (PDMS). Frank Fischer, leveraging over 30 years of experience in senior management roles within medical devices, notably serves as Chief Executive Officer since the company's inception. His illustrious career spans various key roles including his tenure at Heartport, Inc., Ventritex, Inc., and Cordis Corporation.
Underpinning its governance structure, NeuroPace is guided by executives such as Rebecca Kuhn, serving as Chief Financial Officer and Vice President of Finance and Administration since May 2000. Her extensive financial background includes contributions to the initial public offering of Heartport, Inc., alongside prior roles at Reebok International, Inc., and Arthur Andersen & Co. Dr. Martha M.D. Morrell oversees clinical operations as both Chief Medical Officer and Clinical Professor at Stanford University, drawing from her experiences as Director of the Columbia Comprehensive Epilepsy Center.
Additionally, Andre Marquette, who joined in April 2017 as Chief Commercial Officer, brings over two decades of global healthcare commercial experience. Prior engagements with notable companies such as Visualase and St. Jude Medical reinforce his leadership capabilities in executing strategic business initiatives.
Strategically based in Mountain View, CA (Mailing Address: 455 N. Bernardo Avenue), NeuroPace remains committed to patient education and support services, ensuring comprehensive accessibility for individuals utilizing the RNS System. This dedication is highlighted by their Patient Educators and Ambassadors who facilitate informed user engagement through various communication channels. Prospective insights into the company's operations are available on their website at neuropace.com.
NeuroPace maintains a robust corporate presence with several registered offices across states such as CA, CO, FL; reflecting its expansive operation footprint in delivering groundbreaking epilepsy treatment solutions.
KEY FACTS ABOUT NEUROPACE, INC.
-
US Businesses
-
Companies in Florida
-
Broward County Companies
- Company name
- NEUROPACE, INC.
- Status
- Active
- Filed Number
- F16000001158
- FEI Number
- 22-3550230
- Date of Incorporation
-
March 10, 2016
Age - 10 years
- Home State
- DE
- Company Type
- Foreign for Profit
CONTACTS
- Website
- http://neuropace.com
- Phones
-
(866) 726-3876
(650) 237-2700
(650) 237-2701
(888) 646-8483
NEUROPACE, INC. NEAR ME
- Principal Address
- 455 N. Bernardo Avenue,
Mountain View,
CA,
94043,
US
See Also